ABANDONED - NO STATEMENT OF USE FILED
no statement of use filed
on 14 May 2012
Last Applicant/ Owned by
Suite 290
Alpharetta
GA
30005
Serial Number
77561097 filed on 03rd Sep 2008
Registration Number
N/A
Filing Basis
1. intent to use
2. intent to use current
Disclaimer
NO DATA
ILUVIEN
Drug delivery agents consisting of polymer compounds that facilitate the delivery of pharmaceuticals for the treatment of macular edema, macular disease, retinal disease, glaucoma, and occular allegry; pharmaceutical preparations for the treatment of macular edema, macular disease, retinal disease, glaucoma, and occular allegry Sustained drug delivery systems for ocular drugs
Classification Information
Class [005]
Pharmaceutical Products
Drug delivery agents consisting of polymer compounds that facilitate the delivery of pharmaceuticals for the treatment of macular edema, macular disease, retinal disease, glaucoma, and occular allegry; pharmaceutical preparations for the treatment of macular edema, macular disease, retinal disease, glaucoma, and occular allegry
Class [010]
Medical Instrument Products
Sustained drug delivery systems for ocular drugs
Mark Details
Serial Number
No 77561097
Mark Type
No Service/Collective Mark
Attorney Docket Number
No 1033974/105
44D Filed
No
44D Current
No
44E filed
No
44E Current
No
66A Filed
No
66A Current
No
Current Basis
No
No Basis
No
Design Code(s)
26.17.01 -
Straight line(s), band(s) or bar(s)
26.17.05 -
Horizontal line(s), band(s) or bar(s)
Legal History
| Status Date | Action Taken |
|---|---|
| 05th Jun 2013 | ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY |
| 14th May 2012 | ABANDONMENT - NO USE STATEMENT FILED |
| 14th May 2012 | ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILED |
| 11th Oct 2011 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
| 08th Oct 2011 | EXTENSION 5 GRANTED |
| 07th Oct 2011 | TEAS CHANGE OF CORRESPONDENCE RECEIVED |
| 07th Oct 2011 | TEAS EXTENSION RECEIVED |
| 07th Oct 2011 | EXTENSION 5 FILED |
| 14th Apr 2011 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
| 13th Apr 2011 | EXTENSION 4 GRANTED |